Skip to main content

Table 2 HR, PVCs morphology, PVCs burden and ablation procedure characteristics

From: Metabolic syndrome is associated with a poor outcome in patients affected by outflow tract premature ventricular contractions treated by catheter ablation

Variable

General population

Group 1 (with MS)

Group 2 (without MS)

P Value

(n = 24)

(n = 66)

HR baseline (bpm)

67 ± 10

72 ± 11

65 ± 10

0.015

PVC burden

7455 ± 2021

8226 ± 2 407

7263 ± 1766

0.042

QS wave in DI n (%)

23 (25.6%)

4 (16.6%)

19 (28.7%)

0.244

Precordial transition before V4 n (%)

11 (12.2%)

2 (8.3%)

9 (13.6%)

0.721

Fluoroscopic time (min)

22.8 ± 10.2

22.7 ± 8.0

20.5 ± 9.1

0.299

RF time (min)

6.54 ± 3.4

7.2 ± 2.8

6.2 ± 3.5

0.206

Procedural time (min)

147.55 ± 30.8

163.9 ± 39.1

141 ± 24

0.002

  1. Variables are expressed as mean ± SD or median (IQR: 25th percentile, 75th percentile) if not normally distributed.
  2. AADs, antiarrhythmic drugs; HR, heart rate in beats for minute (bpm); PVC, premature ventricular beats; QS wave in DI derivation on surface ecg; RF, radiofrequency catheter ablation.